Anti-cardiolipin IgM antibodies
The IgM anticardiolipin antibody test is performed in the diagnosis of antiphospholipid syndrome—an autoimmune disease associated with blood clotting disorders and obstetric complications.

ClinicLab
- Test description
During the test, the level of IgM anticardiolipin antibodies is measured. This test is used in the diagnosis of antiphospholipid syndrome—an autoimmune disease associated with blood clotting disorders and obstetric complications.
When to perform the test?
The test is recommended if the patient has experienced episodes of venous or arterial thrombosis and/or recurrent obstetric failures (especially in the second and third trimesters).
Conditions:
IgM anticardiolipin antibodies are measured in the diagnosis of conditions such as Antiphospholipid Syndrome (APS).
Symptoms:
The IgM anticardiolipin antibody test is performed if symptoms such as blood clots, especially in the lower limbs, recurrent migraines (in women), concentration and memory issues, dementia, hypertension, pulmonary embolism, difficulty maintaining pregnancy, intrauterine fetal death, and spontaneous miscarriages are observed.